These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8490109)

  • 1. Influence of food on the disposition of the monoamine oxidase-A inhibitor brofaromine in healthy volunteers.
    Degen PH; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1993 Apr; 14(3):209-15. PubMed ID: 8490109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.
    Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age, frailty and liver function on the pharmacokinetics of brofaromine.
    Zeeh J; Fuchs L; Bergmann W; Antonin KH; Degel F; Bieck P; Platt D
    Eur J Clin Pharmacol; 1996; 49(5):387-91. PubMed ID: 8866634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
    Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
    Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers.
    Cardot JM; Lecaillon JB; Czendlik C; Godbillon J
    Biopharm Drug Dispos; 1998 May; 19(4):259-62. PubMed ID: 9604126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.
    Fahlén T; Nilsson HL; Borg K; Humble M; Pauli U
    Acta Psychiatr Scand; 1995 Nov; 92(5):351-8. PubMed ID: 8619339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A.
    Garcia-Borreguero D; Lauer CJ; Ozdaglar A; Wiedemann K; Holsboer F; Krieg JC
    Pharmacopsychiatry; 1992 Nov; 25(6):261-4. PubMed ID: 1494591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.
    Clarke A; Brewer F; Johnson ES; Mallard N; Hartig F; Taylor S; Corn TH
    J Neural Transm (Vienna); 2003 Nov; 110(11):1241-55. PubMed ID: 14628189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brofaromine (CGP 11 305 A): estimation of plasma concentrations by a biologic technique as compared to liquid chromatography.
    Fritze J; Becker T; Ziegler V; Laux G; Bieck P; Sofic E; Riederer P
    J Neural Transm Suppl; 1990; 32():197-201. PubMed ID: 2089091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brofaromine: a monoamine oxidase-A and serotonin uptake inhibitor.
    Waldmeier PC; Glatt A; Jaekel J; Bittiger H
    Clin Neuropharmacol; 1993; 16 Suppl 2():S19-24. PubMed ID: 8313393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
    Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brofaromine (CGP 11 305 A) in treatment of depression: biological estimation of plasma concentrations.
    Fritze J; Becker T; Ziegler V; Laux G; Riederer P
    Pharmacopsychiatry; 1990 May; 23(3):131-4. PubMed ID: 2374771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional action of brofaromine on rat brain MAO-A and MAO-B.
    Gerardy J; Dresse A
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1141-55. PubMed ID: 9829294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the new monoamine oxidase inhibitor brofaromine and its major metabolite in biological material by gas chromatography with electron-capture detection.
    Schneider W; Keller B; Degen PH
    J Chromatogr; 1989 Mar; 488(1):275-82. PubMed ID: 2715286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of monoamine oxidase by brofaromine.
    Anderson MC; Waldmeier PC; Tipton KF
    Biochem Pharmacol; 1991 Jun; 41(12):1871-7. PubMed ID: 2039542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
    J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of fluvoxamine given with and without food.
    Van Harten J; Van Bemmel P; Dobrinska MR; Ferguson RK; Raghoebar M
    Biopharm Drug Dispos; 1991 Nov; 12(8):571-6. PubMed ID: 1801963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR; Antonin KH; Schmidt E
    Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food increases the bioavailability of mefloquine.
    Crevoisier C; Handschin J; Barré J; Roumenov D; Kleinbloesem C
    Eur J Clin Pharmacol; 1997; 53(2):135-9. PubMed ID: 9403285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.